Key facts
- This page summarizes Jonathan D. Root's Form 4 filing for Edgewise Therapeutics, Inc. (EWTX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 28 Feb 2022, 19:04.
Jonathan D. Root - 25 Feb 2022 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)
- Reporting relationship
- Director
- Issuer ticker
- EWTX
- Reported as of
- 25 Feb 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 28 Feb 2022, 19:04:48 UTC
- Prior SEC filing
- 15 Dec 2021
- Next SEC filing
- 27 May 2022
- Source filing
- View source filing
- Reporting owner signature
- Dale Holladay, Attorney in Fact for the Reporting Person
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jonathan D. Root filed Form 4 for Edgewise Therapeutics, Inc. (EWTX) on 28 Feb 2022.
Change
- Previous filing in this sequence was filed on 15 Dec 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EWTX
transaction
Common Stock
Other
- Transaction value
- Shares
- -3,473,543
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 25 Feb 2022
- Ownership
- Directly owned by USVP XI
- Footnotes
- F1, F2
EWTX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 15,625
- Date
- 25 Feb 2022
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents a pro-rata, in-kind distribution by U.S. Venture Partners XI, L.P. without additional consideration to its partners.
Footnote F2
These securities are held of record by U.S. Venture Partners XI, L.P. (''USVP XI''). Presidio Management Group XI, L.L.C. ("PMG XI"), the general partner of USVP XI, has sole voting and dispositive power with respect to the shares held by USVP XI. The Reporting Person is a managing member of PMG XI with additional rights with respect to the issuer's securities, and may be deemed to have sole voting and dispositive power with respect to such shares. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein.